Iain James Mackay net worth and biography

Iain Mackay Biography and Net Worth

CFO & Exec. Director of GSK

Iain joined GSK and was appointed to the Board as Chief Financial Officer Designate on 14 January 2019. He became Chief Financial Officer on 1 April 2019. He is a member of the GSK Leadership Team.

Iain is responsible for Global Finance and several of the company’s key global functions including Investor Relations and Tech.

Prior to joining GSK, Iain was Group Finance Director at HSBC Holdings plc, a position he held for eight years. A chartered accountant, Iain has worked in Asia, the US and Europe and before HSBC was at General Electric, Schlumberger Dowell and Price Waterhouse. Iain was previously a Trustee of the British Heart Foundation and Chair of its Audit and Risk Committee. Iain holds an MA in Business Studies and Accounting and holds an Honorary Doctorate from Aberdeen University in Scotland.

Iain is a member of the Institute of Chartered Accountants of Scotland.

How do I contact Iain James Mackay?: The corporate mailing address for Mr. Mackay and other GSK executives is 980 GREAT WEST ROAD, BRENTFORD X0, TW8 9GS. GSK can also be reached via phone at 442080475000 and via email at [email protected]. Learn More on Iain James Mackay's contact information.
Has Iain James Mackay been buying or selling shares of GSK?: Iain James Mackay has not been actively trading shares of GSK within the last three months. Learn More on Iain James Mackay's trading history.
Who are GSK's active insiders?: GSK's insider roster includes Sally Jackson (Sr. VP of Global Communications & CEO Office), Iain Mackay (CFO & Exec. Director ), and Emma Walmsley (CEO & Director ). Learn More on GSK's active insiders.
Are insiders buying or selling shares of GSK?: During the last year, GSK insiders bought shares 1 times. They purchased a total of 2,791,930 shares worth more than $22,335,440.00. The most recent insider tranaction occured on September, 27th when Major Shareholder Plc Gsk bought 2,791,930 shares worth more than $22,335,440.00. Insiders at GSK own 10.0% of the company. Learn More about insider trades at GSK.
Information on this page was last updated on 9/27/2024.

Iain James Mackay Insider Trading History at GSK

Iain James Mackay Buying and Selling Activity at GSK

GSK Company Overview

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Today's Range

Now: $33.35

$32.83

$33.50

50 Day Range

MA: $39.08

$33.35

$44.09

2 Week Range

Now: $33.35

$32.83

$45.92

Volume

13,747,891 shs

Average Volume

7,092,211 shs

Market Capitalization

$69.12 billion

P/E Ratio

21.66

Dividend Yield

4.62%

Beta

0.66

Watch this before it gets removed

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.